Literature DB >> 25243622

High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.

N Nakano1, A Kubota1, M Tokunaga1, M Tokunaga1, T Itoyama1, T Makino1, S Takeuchi1, Y Takatsuka1, A Utsunomiya1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25243622     DOI： 10.1038/bmt.2014.204

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection.

Authors:  W Garrett Nichols; Lawrence Corey; Ted Gooley; Chris Davis; Michael Boeckh
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

Review 2.  Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.

Authors:  R Stocchi; K N Ward; R Fanin; M Baccarani; J F Apperley
Journal:  Haematologica       Date:  1999-01       Impact factor: 9.941

3.  High incidence of cytomegalovirus, human herpesvirus-6, and Epstein-Barr virus reactivation in patients receiving cytotoxic chemotherapy for adult T cell leukemia.

Authors:  Masao Ogata; Takako Satou; Rie Kawano; Tetsushi Yoshikawa; Junji Ikewaki; Kazuhiro Kohno; Takeaki Ando; Yasuhiko Miyazaki; Eiichi Ohtsuka; Yoshio Saburi; Hiroshi Kikuchi; Tetsunori Saikawa; Jun-ichi Kadota
Journal:  J Med Virol       Date:  2011-04       Impact factor: 2.327

4.  Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.

Authors:  Christian Junghanss; Michael Boeckh; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Thomas Chauncey; Peter A McSweeney; Marie-Térèse Little; Lawrence Corey; Rainer Storb
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

5.  Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.

Authors:  Hidehiro Itonaga; Jun Taguchi; Takuya Fukushima; Hideki Tsushima; Shinya Sato; Koji Ando; Yasushi Sawayama; Emi Matsuo; Reishi Yamasaki; Yasuyuki Onimaru; Daisuke Imanishi; Yoshitaka Imaizumi; Shinichiro Yoshida; Tomoko Hata; Yukiyoshi Moriuchi; Sumihisa Honda; Yasushi Miyazaki
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-17       Impact factor: 5.742

6.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

7.  Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.

Authors:  Hirohisa Nakamae; Katharine A Kirby; Brenda M Sandmaier; Lalita Norasetthada; David G Maloney; Michael B Maris; Chris Davis; Lawrence Corey; Rainer Storb; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-04-16       Impact factor: 5.742

8.  Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.

Authors:  Michael Boeckh; Wendy Leisenring; Stanley R Riddell; Raleigh A Bowden; Meei-Li Huang; David Myerson; Terry Stevens-Ayers; Mary E D Flowers; Terri Cunningham; Lawrence Corey
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113
  8 in total
  2 in total

Review 1.  Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.

Authors:  Atae Utsunomiya
Journal:  Front Microbiol       Date:  2019-10-01       Impact factor: 5.640

2.  Total Body Irradiation and Risk of Diabetes Mellitus; A Meta-Analysis

Authors:  Kittika Poonsombudlert; Nath Limpruttidham
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.